ARTV insider transaction filings
Artiva Biotherapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen ARTV transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Banerjee Subhashis — Chief Medical Officer | Option exercise (M): 429 @ $1.92 · Sale (S): 429 @ $12 · Option exercise (M): 429 (derivative) @ $0 | EDGAR |
| 2026-07-31 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 20,824 @ $9.99 · Purchase (P): 24,944 @ $9.93 | EDGAR |
| 2026-07-28 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 41,319 @ $9.99 | EDGAR |
| 2026-07-23 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 120,582 @ $9.55 · Purchase (P): 84,124 @ $9.93 · Purchase (P): 59,880 @ $9.96 | EDGAR |
| 2026-07-23 | 4/A | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 6,522 @ $8.94 | EDGAR |
| 2026-07-20 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 152,472 @ $8.93 · Purchase (P): 7,882 @ $8.95 | EDGAR |
| 2026-07-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 15,102 @ $8.97 · Purchase (P): 6,552 @ $8.94 | EDGAR |
| 2026-06-29 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 31,000 @ $8.88 · Purchase (P): 1,876 @ $8.98 | EDGAR |
| 2026-06-16 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 391,019 @ $8.57 · Purchase (P): 15,414 @ $8.99 · Purchase (P): 124,893 @ $8.89 | EDGAR |
| 2026-06-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 479,039 @ $6.91 · Purchase (P): 103 @ $7 · Purchase (P): 548,580 @ $7.91 | EDGAR |
| 2026-05-28 | 4 | GC Corp. — 10% owner GC Cell Corp — 10% owner | Purchase (P): 1,085,069 @ $11.52 · Purchase (P): 347,222 @ $11.52 | EDGAR |
| 2026-05-19 | 4 | Raymon Heather — SVP, Research and Development | Sale (S): 3,095 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Banerjee Subhashis — Chief Medical Officer | Sale (S): 7,037 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 27,116 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Miralles Gines Diego — President & Head of R&D | Grant/award (A): 77,500 @ $0 · Grant/award (A): 232,500 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Horan Christopher — Chief Tech Operations Officer | Sale (S): 7,002 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Sale (S): 8,790 @ $9.01 | EDGAR |
| 2026-05-13 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 6,510,416 @ $11.52 · Purchase (P): 2,170,138 (derivative) @ $11.52 | EDGAR |
| 2026-03-10 | 4 | Huston Thad Allen — Chief Financial Officer | Grant/award (A): 220,000 @ $0 | EDGAR |
| 2026-02-19 | 4 | Sorg Elaine K. — Director | Grant/award (A): 27,500 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Raymon Heather — SVP, Research and Development | Grant/award (A): 46,000 @ $0 · Tax withholding (F): 1,521 @ $4 | EDGAR |
| 2026-02-18 | 4 | Banerjee Subhashis — Chief Medical Officer | Grant/award (A): 102,000 @ $0 | EDGAR |
| 2026-02-18 | 4 | Aslan Fred — President and CEO, Director | Grant/award (A): 366,850 @ $0 · Tax withholding (F): 14,600 @ $4 | EDGAR |
| 2026-02-18 | 4 | Horan Christopher — Chief Tech Operations Officer | Grant/award (A): 117,300 @ $0 · Tax withholding (F): 2,187 @ $4 | EDGAR |
| 2026-02-18 | 4 | Bush Jennifer — COO, CLO, Secy, Compliance Off | Grant/award (A): 117,300 @ $0 · Tax withholding (F): 3,515 @ $4 | EDGAR |
| 2025-12-15 | 4 | Aslan Fred — President and CEO, Director | Sale (S): 3,187 @ $6 | EDGAR |
| 2025-12-12 | 4 | Raymon Heather — SVP, Research and Development | Grant/award (A): 67,253 @ $0 · Disposition to issuer (D): 18,239 (derivative) · Disposition to issuer (D): 12,539 (derivative) · Disposition to issuer (D): 14,819 (derivative) · Disposition to issuer (D): 11,399 (derivative) · Disposition to issuer (D): 10,259 (derivative) | EDGAR |
| 2025-12-12 | 4 | Aslan Fred — President and CEO, Director | Grant/award (A): 869,136 @ $0 · Disposition to issuer (D): 100,577 (derivative) · Disposition to issuer (D): 51,463 (derivative) · Disposition to issuer (D): 257,319 (derivative) · Disposition to issuer (D): 26,450 (derivative) · Disposition to issuer (D): 113,999 (derivative) · +1 more | EDGAR |
| 2025-12-12 | 4 | Horan Christopher — Chief Tech Operations Officer | Grant/award (A): 107,156 @ $0 · Disposition to issuer (D): 77,519 (derivative) · Disposition to issuer (D): 9,119 (derivative) · Disposition to issuer (D): 20,519 (derivative) | EDGAR |
| 2025-12-12 | 4 | Bush Jennifer — COO, CLO, Secy, Compliance Off | Grant/award (A): 84,877 @ $0 · Disposition to issuer (D): 41,039 (derivative) · Disposition to issuer (D): 9,119 (derivative) · Disposition to issuer (D): 14,202 (derivative) · Disposition to issuer (D): 20,519 (derivative) | EDGAR |
| 2025-11-17 | 4 | Raymon Heather — SVP, Research and Development | Tax withholding (F): 1,375 @ $3.25 | EDGAR |
| 2025-11-17 | 4 | Krishnamohan Neha — Chief Financial Officer | Tax withholding (F): 3,490 @ $3.25 | EDGAR |
| 2025-11-17 | 4 | Aslan Fred — President and CEO, Director | Tax withholding (F): 6,347 @ $3.25 · Sale (S): 6,375 @ $3.38 | EDGAR |
| 2025-11-17 | 4 | Horan Christopher — Chief Tech Operations Officer | Tax withholding (F): 1,899 @ $3.25 | EDGAR |
| 2025-11-17 | 4 | Bush Jennifer — COO, CLO, Secy, Compliance Off | Tax withholding (F): 3,055 @ $3.25 | EDGAR |
| 2025-10-17 | 4 | Aslan Fred — President and CEO, Director | Sale (S): 25,500 @ $6 | EDGAR |
| 2025-08-18 | 4 | Aslan Fred — President and CEO, Director | Tax withholding (F): 4,472 @ $2.13 · Sale (S): 25,500 @ $2.73 · Tax withholding (F): 4,472 @ $2.75 | EDGAR |
| 2025-08-18 | 4 | Raymon Heather — SVP, Research and Development | Tax withholding (F): 745 @ $2.13 · Tax withholding (F): 1,639 @ $2.75 | EDGAR |
| 2025-08-18 | 4 | Krishnamohan Neha — Chief Financial Officer | Tax withholding (F): 1,341 @ $2.13 · Tax withholding (F): 5,813 @ $2.75 | EDGAR |
| 2025-08-18 | 4 | Horan Christopher — Chief Tech Operations Officer | Tax withholding (F): 1,341 @ $2.13 · Tax withholding (F): 3,577 @ $2.75 | EDGAR |
| 2025-08-18 | 4 | Bush Jennifer — COO, CLO, Secy, Compliance Off | Tax withholding (F): 1,937 @ $2.13 · Tax withholding (F): 6,409 @ $2.75 | EDGAR |
| 2025-06-26 | 4 | Stoppel Laura — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Baker Daniel G. — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Miralles Gines Diego — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | MOORE ALISON — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | DANIELS BRIAN — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | HOUGEN ELIZABETH L — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | Banerjee Subhashis — Chief Medical Officer | Grant/award (A): 50,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Aslan Fred — President and CEO, Director | Grant/award (A): 200,000 @ $0 | EDGAR |
Recent 8-K events — Artiva Biotherapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-12 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARTV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →